Paramount Global (PARAA)

Blueprint Medicines Revenue

Paramount Global had revenue of $6.85B in the quarter ending June 30, 2025, with 0.53% growth. This brings the company's revenue in the last twelve months to $28.76B, down -1.75% year-over-year. In the year 2024, Paramount Global had annual revenue of $29.21B, down -1.48%.

• Revenue (ttm): $28.76B
• Revenue Growth: -1.75%
• P/S Ratio: 0.27
• Revenue / Employee: $1,546,022
• Employees: 18,600
• Market Cap: 7.68B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	29.21B	-439.00M	-1.48%
Dec 31, 2023	29.65B	-502.00M	-1.66%
Dec 31, 2022	30.15B	1.57B	5.49%
Dec 31, 2021	28.59B	3.30B	13.06%
Dec 31, 2020	25.29B	-1.71B	-6.34%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.